Profile
Marco Liguori is currently the General Manager at Orphan Europe SARL.
Previously, he worked as the VP, Director-Special Care & Orphan Drug at Recordati SpA in 2011.
He holds an MBA from INSEAD.
Marco Liguori active positions
| Companies | Position | Start |
|---|---|---|
Orphan Europe SARL
 Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | President | - |
Former positions of Marco Liguori
| Companies | Position | End |
|---|---|---|
| RECORDATI | Corporate Officer/Principal | - |
Training of Marco Liguori
| INSEAD | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RECORDATI | Health Technology |
| Private companies | 1 |
|---|---|
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | Health Technology |
- Stock Market
- Insiders
- Marco Liguori
